BioSig Technologies signs agreement with Texas Cardiac Arrhythmia Institute for first-in-human studies

BioSig Technologies signed an agreement with Texas Cardiac Arrhythmia Institute to conduct first-in-human studies using the PURE EP System at St. David's Medical Center in Austin, Texas.

“BioSig Technologies, Inc. today announced that the Company has signed an agreement with Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center in Austin, Texas to conduct First-in-Human studies using the PURE EP™ System.”financialnewsmedia.com

• 1 source
• financialnewsmedia.comBioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies - Financial News MediaadminNov 27, 2018

Summarized from public sources; check the original articles before acting on it.